Evolocumab Benefits Accrue With Longer Follow-up: FOURIER OLE ...Middle East

Chief among them was a reduction in cardiovascular mortality not observed in the pivotal trial that led to US approval of the drug. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Evolocumab Benefits Accrue With Longer Follow-up: FOURIER OLE )

Also on site :

• Kremlin comments on possible US strike on Iran
• Israel’s war on Iran is not about nuclear weapons
• Former NBA Player and 'Survivor' Alum Opens Up About Heart Transplant